Five things for pharma marketers to know: Tuesday, August 21, 2018
FDA gives Keytruda new real-time approval; AstraZeneca headquarters construction boondoggle; Lack of sleep costs U.S. economy hundreds of billions per year.
Novo Nordisk's Ozempic takes on Lilly's Trulicity in DTC showdown
The two diabetes rivals air competing TV spots as they compete for GLP-1 supremacy.
Evoke Group rebrands, reorganizes subsidiary agencies
The renamed Evoke will replace the individual agency network with six areas of focus.
Q&A: Matt McNally on the road ahead for Outcome Health and the state of the POC union
Matt McNally, CEO of Outcome Health, shares his thoughts on post-controversy Outcome Health and the overall state of the point-of-care union.
Media buyers form group to advance standards in POC
Among the group's members are media agencies that had pulled healthcare ad spend from the POC channel in the wake of a scandal 10 months ago.
POC community makes good on promises of transparency and accountability
After a scandal with one of point of care's biggest players, we examine how the community is living up to its promise of greater transparency.
Five things for pharma marketers to know: Monday, August 20, 2018
Azar says HHS can eliminate rebates; States pass measures to stop drug price increases; 'Poor oversight' blamed for California sitting on cash to treat mentally ill.
Five things for pharma marketers to know: Friday, August 17, 2018
Purdue Pharma taps financial restructuring firm; White House wants opioid-production cut; NYU to make med school free.
David Gideon, medical media icon and industry stalwart, dies at 75
For Gideon, honoring those who helped build the medical ad industry became a labor of love.
First generic version of EpiPen approved by FDA
Teva's generic EpiPen injector received a thumbs up from the FDA on Thursday.
Study: FDA anti-tobacco campaign prevented 350,000 teens from smoking
The study estimated the FDA's anti-smoking campaign, The Real Cost, saved $31 billion in smoking-related costs to society.
Five things for pharma marketers to know: Thursday, August 16, 2018
CDC estimates 72,000 died of drug overdoses in 2017; Genentech to lay off 200-plus employees; Pfizer invests up to $425 million in BioNTech.
Five things for pharma marketers to know: Wednesday, August 15, 2018
Alphabet invests more in Oscar; ViiV's HIV injection proves effective; Gilead's chief medical officer departs in latest executive exit.
Novartis names Klaus Moosmayer ethics, risk, and compliance chief
Moosmayer is set to join the pharma company in December.
Healix's Jeffrey Erb on what pharma giants consolidating accounts means for agencies
Bigger budgets, fewer accounts. That's the dilemma facing pharma marketers as drugmakers consolidate work.
Five things for pharma marketers to know: Tuesday, August 14, 2018
Icahn drops bid to stop Cigna-Express Scripts tie-up; Bayer joins Evotec-Haplogen partnership to find COPD treatments; Orchard raises $150 million in Series C funding.
